An interventional study of Da Vinci SP Surgical System in Upper Tract Urothelial Cancer, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2025-05-23.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment
To evaluate patient-reported outcomes of radical nephroureterectomy using single-port robotic surgery
To evaluate safety, surgical outcomes, patient characteristics, and patient-reported outcomes of radical nephroureterectomy using single-port robotic surgery
National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Single-Port Robot-Assisted Surgery Using Da Vinci SP Surgical System for Patients with Upper Tract Urothelial Cancer
Device: Da Vinci SP Surgical System
Da Vinci SP Surgical System
Incidence of conversion rate
The primary performance endpoint will be assessed as the ability to successfully completed the planned procedure with da Vinci SP System, with no conversion to alternative surgery including open surgery or laparoscopy.
Time frame: During Surgery
Perioperative Parameters: Operative Time
First skin incision to closure of wound by minutes.
Time frame: immediately after the surgery
Perioperative Parameters: Console Time
Surgeon on Console Time by minutes
Time frame: immediately after the surgery
Perioperative Parameters: Transfusion
Blood transfusion amount by bags
Time frame: immediately after the surgery
Perioperative Parameters: Estimated Blood Loss
Estimated blood loss by mL
Time frame: immediately after the surgery
Postoperative Parameters: Length of Stay
Total length of stay = discharge date - admission date
Time frame: 30 days post operation
Complication
Intraoperative and/or postoperative complication rate in 30 days by Clavien-Dindo Classification
Time frame: 30 days post operation
Postoperative Parameters: Readmission
Readmission rate by %
Time frame: 30 days post operation
Postoperative Parameters: Reoperation
Reoperation rate by %
Time frame: 30 days post operation
Perioperative Mortality
Mortality by %
Time frame: 30 days post operation
Pain Score
measured by Visual Analogue Scale (VAS) for pain assessment at baseline, post operation, and discharge day. VAS ranged from 0 to 10, representing no pain to extreme pain.
Time frame: 30 days post operation
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital